MNBIX
Price
$19.93
Change
+$0.12 (+0.61%)
Updated
Jan 30 closing price
Net Assets
548.56M
RLEFX
Price
$35.37
Change
+$0.24 (+0.68%)
Updated
Jan 30 closing price
Net Assets
241.03B
Ad is loading...

MNBIX vs RLEFX

Header iconMNBIX vs RLEFX Comparison
Open Charts MNBIX vs RLEFXBanner chart's image
Manning & Napier Pro-Blend Extnd Term I
Price$19.93
Change+$0.12 (+0.61%)
VolumeN/A
Net Assets548.56M
American Funds American Balanced R5E
Price$35.37
Change+$0.24 (+0.68%)
VolumeN/A
Net Assets241.03B
MNBIX vs RLEFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MNBIX vs. RLEFX commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNBIX is a StrongBuy and RLEFX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 241B vs. MNBIX (549M). RLEFX pays higher dividends than MNBIX: RLEFX (2.42) vs MNBIX (1.98). MNBIX was incepted earlier than RLEFX: MNBIX (17 years) vs RLEFX (9 years). RLEFX is a more actively managed with annual turnover of: 171.00 vs. MNBIX (56.00). RLEFX has a lower initial minimum investment than MNBIX: RLEFX (250) vs MNBIX (1000000). RLEFX annual gain was more profitable for investors over the last year : 12.30 vs. MNBIX (8.23). RLEFX return over 5 years is better than : 34.94 vs. MNBIX (2.24).
MNBIXRLEFXMNBIX / RLEFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years9 years-
Gain YTD3.0163.12097%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets549M241B0%
Annual Yield % from dividends1.982.4282%
Returns for 1 year8.2312.3067%
Returns for 3 years3.6815.2024%
Returns for 5 years2.2434.946%
Returns for 10 years0.19N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IPAR143.293.26
+2.33%
Interparfums Inc
ACGL94.580.76
+0.81%
Arch Capital Group Ltd
DSGN4.970.03
+0.61%
Design Therapeutics
GENI8.940.04
+0.45%
Genius Sports Limited
XLO0.69-0.02
-2.88%
Xilio Therapeutics